Category Archives: Pharmacogenomics

The Most Recent study on the Genealogy Products and Services Market Research provides a profound comprehension of the various market dynamics like trends, drivers, the challenges, and opportunities. The report further elaborates on the micro and macro-economic elements that are predicted to shape the increase of the Genealogy Products and Services market throughout the forecast period (2019-2029).

The introduced study elucidates the crucial indicators of Market growth which comes with a thorough analysis of this value chain, CAGR development, and Porters Five Forces Analysis. This data may enable readers to understand the quantitative growth parameters of this international industry that is Genealogy Products and Services .

Analytical Insights Included from the Genealogy Products and Services Market Report

Request Sample Report @ https://www.factmr.co/connectus/sample?flag=S&rep_id=3083

Genealogy Products and Services Market Segmentation Assessment

The increase prospects of this market in various Regions are studied in the report together with details like the regulatory framework, political, and financial outlook of each region.

competitive landscape, get in touch with our experts

Demand for Genetic Testing to Surge as Preventive Healthcare and Pharmacogenomics Gain Traction

Preventive healthcare is gradually gaining center stage with consumers becoming increasingly aware of the benefits of the practice. Genetic testing plays a vital role in preventive healthcare as it provides a potential technique for diagnosis of rare diseases. It is showing promising prospects for precisely predicting the risk of developing a particular disease by studying the complex genetic markup of the population.

Numerous researchers claiming the efficacy of genetic testing are promoting its adoption. The procedure can potentially enable doctors to suggest measures to prevent the development of a certain health condition. Investments by governments are further fueling the growth of the genealogy products & services market. For instance, the National Health Service in England recently announced its plan to expand genetic testing capabilities to improve the quality of health services in the country.

Development of pharmacogenomics is another factor imperative to genealogy products & services market growth. Pharmacogenomics is the study of genetics to predict the impact of medication on the human body. Genetic testing is already being leveraged for prescribing personalized medications in the treatment of panic disorder, anxiety, schizophrenia, bipolar disorder, and post-traumatic disorder.

For detailed analysis on all the key market factors, request a sample

Genealogy Service Providers Widening the Scope of Application

Genealogy products & services providers are foraying into an assortment of different verticals to extend their consumer base. Use of genealogy and genetic testing for offering personalized services in a multitude of markets is gradually gaining traction. Companies such as EpigenCare and SkinGenie are leveraging genetic testing to provide skin care products that particularly complement the genetic makeup of a persons skin. On the other hand, Pheramor, a company based in Houston, is using genetic testing for finding people their compatible partners. Another example of the widening scope of genealogy products & services is Vinome, a company which provides a thorough report of the different wines a person may have an affinity for after studying their genetic makeup.

Aggressive marketing techniques, coupled with growing consumer inquisitiveness about such implications of genealogy, is aiding these applications in gaining popularity which, in turn, is expected to bolster genealogy products & services market growth.

Technological Innovations Complementing Market Growth

Genealogy products & services market is estimated to benefit from headways in technology. Genealogy products & services companies are harnessing data analytics, machine learning, big data, and artificial intelligence for effectively storing and analyzing a large amount of data. Genealogy products and services companies are increasingly using online platforms for marketing their services and increaing penetration into the market.

Enhanced DNA sequencing technology is further helping companies in analyzing genetic sequences at a faster rate and affordable costs while providing them accurate results. For instance, scientists in Estonia were successfully able to develop a genetic testing technology which analyzes genes at single-molecule level, paving way for enhancing the efficacy of precision medicines at lower costs. Other factors such as the development of sophisticated infrastructure for efficient sharing of huge DNA datasets is estimated to bolster genealogy products & services market growth.

Data Confidentiality Continues to Pose Challenges

The current status-quo in the genealogy products andservices market involves digital storage of data exposing it to the dangers of cybercrime and hacking. Additionally, genetic testing also influences life insurance premiums with companies considering results from the process to determine premiums. Insurance companies in Australia include genetic tests results in the risk classification for underwriting and are allowed to deny insurances in case the results predict the development of life-threatening diseases in the future. Further, the procedure can potentially cause discrimination during employment with the employers denying applications on the possibility of an applicant developing a disability in the future. Although the law prohibits companies from doing so, illegal leaking of information can influence the process.

While registering for genealogy processes, consumers compulsorily need to provide valuable information such as credit card numbers, name, and email addresses. This makes the companies a favorite target of cybercriminals. In addition to this, the increasing instances of data breaches are estimated to discourage consumers from using the services. Presence of lax or no regulations for classifying genetic testing as effective is adding to consumers confusion and poses a vital challenge to the genealogy products & services market growth.

Definition

Genealogy is the study of heritages and lineages, and comprises lineage tracing, DNA testing, cemetery records, family tree creation, and other related services.

About the Report

The report on genealogy products and services market provides an all-inclusive assessment of all the factors influencing the genealogy products & services market. Additionally, the report on genealogy products & services market provides a qualitative and quantitative assessment of each of the factors identified. The report also includes an opportunity assessment of the genealogy products & services market. An assessment of the competitive landscape prevalent in the genealogy products & services market has also been included in the report.

Market Structure

The report on genealogy products andservices market segments the genealogy products & services market on the basis of category and region. Based on the category, the genealogy products & services market can be segmented into family records, family tree, forum, cemetery, newspapers, blogs, links, and DNA testing.

Additional Questions Answered

In addition to the aforementioned insights about the genealogy products & services market, the report answers the following vital questions about the genealogy products andservices market:

Research Methodology

The report on genealogy products & services market is a consequence of robust and exhaustive research methodology. A two-step research process was employed to obtain insights into the genealogy products andservices market. Interviewing experts from the genealogy products & services market formed the basis of primary research while secondary research was conducted by thoroughly studying genealogy products & services trade journals, paid sources, and other industry-related publications. Results from both the steps were triangulated to produce an accurate forecast of the genealogy products andservices market.

Request methodologyof this Report.

Request Methodology On This Report @ https://www.factmr.co/connectus/sample?flag=RM&rep_id=3083

The Report intends to eliminate the subsequent doubts regarding the Genealogy Products and Services market:

Reasons To Choose Fact.MR:

Ask analyst about this report at https://www.factmr.co/connectus/sample?flag=AE&rep_id=3083

Read the original post:
Genealogy Products and Services Market Global Opportunity Analysis and Forecast 2018 to 2024 - TechnoWeekly

Imaging is now becoming an increasing important tool in both clinical and research. A wide range of imaging techniques commercially available provides sensitivity to visualization of brain structure and function from the level of individual molecules to whole brain. Hence, brain imaging helps the researchers or the physicians to identify the area of brain which are affected by neurological disorders. Moreover, brain imaging also help in formulating new strategies for the treatment of brain disorders and similarly enable imaging of the brain structure or for the diagnosis of metabolic diseases. Imaging methods are non invasive which also allow researchers to identify neural networks involved in the cognitive pathway. Likewise, neuroinformatics is the branch of science which is related with the organization of neuroscience data by the application of analytical tools and computational models. Neuroinformatics comprises multidimensional databases and software systems that store and analyze data from the genetic to the behavioral level. Similarly, biomarkers is defined as measurable indicator that are used for identification of particular disease. Biomarkers are used for identification of progress of disease, evaluation of most effective therapeutic regime for particular or drug target identification. Thus, in the field of neuroscience biomarker plays an essential role in identification of number of neurological disorders and abnormalities.

Request a PDF Brochure https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3851

Factors such as increase in geriatric population, investment in R&D and improved understanding of the nature of neurologic diseases are driving the market growth globally. Since, aged population is more prone to brain disorders therefore; increase in geriatric population will likely increase the neurodiagnostics market worldwide. Additionally, as per the World Health Organization, by 2020 nearly 14.1% of the world population will suffer from neurologic disorders which would further lure manufacturers to venture into this market.

Request a Sample of Brain Imaging, Biomarkers and NeuroInformatics Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3851

The market for neurodiagnostics can be segmented on the basis of three primary market segments neuroimaging market, in vitro diagnostics market and neuroinformatics market. Neuroimaging segment can be categorized into computed tomography (CT), nuclear medicine imaging (PET, SPECT), magneto-encepahlography (EEG), electro-encephalography and other imaging software. In vitro diagnostics segments can be subdivided into protein biomarker assay, pattern recognition diagnostics, genetic testing and pharmacogenomics. Likewise, the market for neuroinformatics is subdivided into software used for diagnostics and storage namely IBM Blue Brain Project, Paul Allen Brain Atlas Project and other software. Brain imaging techniques allows the technicians to visualize how quickly drugs reach to the receptors and their action mechanism. Moreover, these techniques also allow visualization of changes in brain activity after long term usage of drug.

Request for Analysis of COVID19 Impact on Brain Imaging, Biomarkers and NeuroInformatics Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=3851

Geographically, the market for brain imaging, neuroinformatics and biomarkers can be segmented into four regions namely North America, Europe, Asia-Pacific and Rest of the World. Currently North America and Europe account for the largest share of the market. It has been estimated that approximately 100 million people are suffering from brain or nervous system disorders such as Alzheimers disease, schizophrenia, Parkinsons disease, sleep disorders and others. Likewise, according to the National Institute of Mental Health in the U.S. about 1 in 4 adults suffer from brain disorders every year, with almost 6% of the population suffer from serious disabilities. Thus, for the diagnosis of these disorders rapidly new tools are being developed for more patients centered and personalized treatment. In the near future Asia-Pacific region is expected to witness significant growth to meet the massive unmet need for early diagnosis and disease monitoring.

Pre-Book Brain Imaging, Biomarkers and NeuroInformatics Market Report https://www.transparencymarketresearch.com/checkout.php?rep_id=3851&ltype=S

Abbot Diagnostics, Brain Resource, Advanced Brain Monitoring, Electrical Geodesics, Johnson & Johnson, GE Healthcare, NeuroVigil, Bio-Rad, Philips Healthcare, Quest Diagnostics, Aspect Medical (Covidien), NeuroVista, Natus Medical, BrainScope, Zynex and others are some of the major players operating in brain imaging, neuroinformatics and biomarkers market.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers or customers journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,90 Sate Street, Suite 700,Albany, NY 12207Tel: +1-518-618-1030USA Canada Toll Free: 866-552-3453Website:https://www.transparencymarketresearch.com/

Read More Reports: https://www.prnewswire.com/news-releases/women-opting-for-late-motherhood-driving-demand-for-non-invasive-prenatal-testing-transparency-market-research-301005822.html

Follow this link:
Brain Imaging, Biomarkers and NeuroInformatics Market to Witness Exponential Growth by 2024 - PRnews Leader

This article was originally published here

Pharmacogenomics. 2020 Oct 30. doi: 10.2217/pgs-2020-0066. Online ahead of print.

ABSTRACT

Background: Despite potential benefits, the practice of incorporating pharmacogenomics (PGx) results in clinical decisions has yet to diffuse widely. In this study, we conducted a review of recent discussions on data standards and interoperability with a focus on sharing PGx test results among health systems. Materials & methods: We conducted a literature search for PGx clinical decision support systems between 1 January 2012 and 31 January 2020. Thirty-two out of 727 articles were included for the final review. Results: Nine of the 32 articles mentioned data standards and only four of the 32 articles provided solutions for the lack of interoperability. Discussions: Although PGx interoperability is essential for widespread implementation, a lack of focus on standardized data creates a formidable challenge for health information exchange. Conclusion: Standardization of PGx data is essential to improve health information exchange and the sharing of PGx results between disparate systems. However, PGx data standards and interoperability are often not addressed in the system-level implementation.

PMID:33124487 | DOI:10.2217/pgs-2020-0066

Link:
The inclusion of health data standards in the implementation of pharmacogenomics systems: a scoping review - DocWire News

Oct-2020 Updated Report: Final Report will add the analysis of the impact of COVID-19 on this industry.

Global Pharmacogenomics (PGX) Market Research Report presents a competitive assessment and detailed statistical analysis on Pharmacogenomics (PGX) Industry prospects. The Pharmacogenomics (PGX) Report will enlighten the readers with market dynamics and market trends to provide a holistic market overview. The key aspects of Pharmacogenomics (PGX) Industry like market growth, market dynamics, threats and cost structures are presented in the report. The emerging market trends, latest development, R&D status, and key vendors are analysed at depth. The Pharmacogenomics (PGX) report is segmented based on product type, application and top geographical regions.

To Understand How Covid-19 Impact on this industry. Get Free Sample Report:

https://www.globalmarketers.biz/report/life-sciences/global-pharmacogenomics-(pgx)-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/155320#request_sample

Major players covered in this report:

Illumina, Inc.GeneDx.Transgenomic, Inc.Pfizer, Inc.Pathway GenomicsOSI PharmaceuticalsGensetMyriad Genetics, Inc.GE HealthcareGeneTechAffymetrix, Inc.Thermo Fisher Scientific23andMe, Inc.Abbott Laboratories

Global Pharmacogenomics (PGX) Market Segmentation:

By Type:

MicroarraySequencingPolymerase Chain ReactionOthers

By Application:

OncologyCardiologyNeurological DisordersOthers

The future Pharmacogenomics (PGX) Industry predictions explain the forecast market values, industry progress, upcoming plans and policies. Also, the volume, value and consumption forecast view is presented from 2019-2026. The strategies implemented by top Pharmacogenomics (PGX) players, as well as historic and present market performance is portrayed in this report. The Pharmacogenomics (PGX) fundamental market overview, market share, import-export status, and pricing structure is presented. The report begins with Pharmacogenomics (PGX) research objectives, definition, market scope and size estimation. The growth rate from 2014-2026 and complete Pharmacogenomics (PGX) Industry picture is covered.

Get Up to 40% Off on purchasing this report, Ask Here for Discount @:

https://www.globalmarketers.biz/discount_inquiry/discount/155320

All top product types, applications and regions namely North America, Europe, Asia-Pacific, South America, and Middle East & Africa are analysed. A complete market outlook from 2014-2026 with country-level analysis for above-mentioned regions is covered in the report. The top countries analysed in the report include United States, Canada, Mexico, France, Germany Italy, UK, Russia, China, Korea, Japan, India, Brazil, South Africa, Egypt, Turkey and Saudi Arabia are profiled in the report. Other regions/countries can be added based on user requirements.

Next segment explains the Pharmacogenomics (PGX) market dynamics presenting the opportunities, risks and market driving forces. Also, the top manufacturers profile analysed in the study explains their business portfolio, market growth, market share for every type and application as well as their geographical presence. A complete estimation of sales margin, price, revenue share and gross margin is explained. The sales and marketing channels of Pharmacogenomics (PGX), traders, distributors and dealers of Pharmacogenomics (PGX) Market are evaluated completely.

Inquire Before Buying Or Ask For More Details:

https://www.globalmarketers.biz/report/life-sciences/global-pharmacogenomics-(pgx)-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/155320#inquiry_before_buying

The Primary Objectives of Pharmacogenomics (PGX) Market Research Report Are As Follows:

The top-down and bottom-up approach is implied to study the Pharmacogenomics (PGX) Market statistics and analytical details. The data is presented in the form of graphs, tables, and figures to provide ease of understanding. The SWOT analysis, investment return analysis and mergers & acquisitions in Pharmacogenomics (PGX) Industry are stated. The changes in business structure, plans & policies and emerging players are analysed in detail. This report will be useful for all market participants and business consultants to understand Pharmacogenomics (PGX) market trends, growth drivers and challenges.

View Full Table Of Content: @

https://www.globalmarketers.biz/report/life-sciences/global-pharmacogenomics-(pgx)-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/155320#table_of_contents

Contact Us:

Name: Alex White

Phone: US: +1(806)4400782/ UK: +44 33 3303 4979

Email: [emailprotected]

See more here:
Global Pharmacogenomics (PGX) Market-Analysis, Recent Trends and Regional Growth Forecast by Types,Applications and Economic Impact on Revenue;...

Dublin, Oct. 30, 2020 (GLOBE NEWSWIRE) -- The "Pain Therapeutics - Drugs, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

The worldwide analgesic markets were analyzed for the year 2019 and projected to 2029. Calculations are based on the epidemiology of various painful conditions and the development of analgesic drugs and devices. Unfulfilled needs for analgesics are identified and strategies are outlined to develop markets for analgesic drugs. The report is supplemented with 77 tables, 25 figures, and 600 selected references to the literature.

Over 500 companies have been identified to be involved in developing or marketing pain therapeutics and 173 of these are profiled in the report along with 156 collaborations. These are a mix of pharmaceutical companies and biotechnology companies.

This report describes the latest concepts of pathomechanisms of pain as a basis for the management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic pain and cancer pain. Because pain is a subjective sensation, it is difficult to evaluate objectively in clinical trials. Various tools for pain measurement are described, including brain imaging.

Most of the currently used analgesic drugs fall into the categories of opioids and nonsteroidal anti-inflammatory drugs such as COX-2 inhibitors. Non-opioid analgesics include ketamine, an N-methyl-D-aspartate receptor antagonist. Adjuvant analgesics include antidepressants and antiepileptic drugs used for the treatment of neuropathic pain. Management of pain is multidisciplinary and includes both pharmacological and non-pharmacological methods such as acupuncture, transcutaneous electrical nerve stimulation and surgery. Various pain syndromes require different approaches in management, for example, the main category of drugs for migraine are triptans such as sumatriptan.

Drug delivery is an important consideration in pain treatment. Controlled release preparations provide a steady delivery of analgesics. Well-known non-injection methods such as transdermal, pulmonary, and intranasal applications have been used. Topical analgesics and local anesthetics are also available. Devices such as implanted pumps are used for the delivery of drugs such as opioids intrathecally (introduction into spinal subarachnoid space by lumbar puncture) in patients with cancer pain.

The wide variety of drugs in development includes opioid receptor ligands, bradykinin antagonists, mPGES-1 inhibitors, glutamate receptor antagonists, substance P and neurokinin receptor antagonists, norepinephrine transporter inhibitors, P2X2 neuron receptor antagonists and nitric oxide-based analgesics. A number of cannabinoids are also in development for pain. Fish-derived tetrodotoxin was initially focused on an indication of opiate addiction withdrawal but is found to have an analgesic action as well. Cone shells contain therapeutically useful peptides including the conotoxins, and one such peptide, ziconotide, has been approved. Various cell and gene therapies are also being developed for the management of pain.

Advances in molecular and biological techniques are markedly advancing our understanding of pain. Understanding the pathophysiology of pain is an important factor in the discovery of rational therapies for pain. Advances in pharmacogenomics and pharmacogenetics are enabling the development of personalized approaches to the management of pain.

Key Topics Covered:

Executive Summary

1. Basic Aspects of Pain

2. Assessment of Pain and Analgesics

3. Pharmacotherapy of Pain

4. Management of Pain

5. Drug Delivery for Pain

6. Drug Development for Pain

7. Safety, Regulatory and Legal issues of pain management

8. Pain Markets

9. Future of Pain Therapeutics

10. Companies Involved in Pain Therapeutics

11. References

For more information about this report visit https://www.researchandmarkets.com/r/9sy2r2

Source: Jain PharmaBiotech

About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Original post:
Global Pain Therapeutics Markets, 2019-2020 & Forecast to 2029 with Profiles of 173 Companies & 156 Collaborations - Benzinga

The Global Pharmacogenomics (PGx) Market report offers key insights into the worldwide Pharmacogenomics (PGx) market. It presents a holistic overview of the market, with an in-depth summary of the markets leading players. The report is inclusive of indispensable information related to the leading competitors in this business sector and carefully analyzes the micro- and macro-economic market trends. The latest report specializes in studying primary and secondary market drivers, market share, the leading market segments, and comprehensive geographical analysis. Vital information about the key market players and their key business strategies, such as mergers & acquisitions, collaborations, technological innovation, and trending business policies, is one of the key components of the report.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2296

The report covers extensive analysis of the key market players in the market, along with their business overview, expansion plans, and strategies. The key players studied in the report include:

Admera Health, Abbott Laboratories, Agena Biosciences, Inc., Dynamic DNA Laboratories, Cancer Genetics, Inc., F. Hoffmann-La Roche Ltd, Genomic Health, Inc., geneOmbio Technologies Pvt Ltd., Laboratory Corporation of America Holdings, and Illumina, Inc., among others.

Furthermore, our market analysts have drawn focus to the significant impact of the COVID-19 pandemic on the global Pharmacogenomics (PGx) market and its key segments and sub-segments. The grave aftereffects of the pandemic on the global economy, and subsequently, on this particular business sphere, have been enumerated in this section of the report. The report considers the key market-influencing parameters, delivering a detailed future impact assessment. The Pharmacogenomics (PGx) market has been devastated by the pandemic, which has culminated in drastic changes to the market dynamics and demand trends.

Products and Services Outlook (Revenue, USD Billion; 2017-2027)

Technology Outlook (Revenue, USD Billion; 2017-2027)

Application Outlook (Revenue, USD Billion; 2017-2027)

End-Use Outlook (Revenue, USD Billion; 2017-2027)

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2296

Moreover, the research report thoroughly examines the size, share, and market volume of the Pharmacogenomics (PGx) industry in the historical years to forecast the same valuations over the forecast duration. It offers exhaustive SWOT analysis, Porters Five Forces analysis, feasibility analysis, and investment return analysis of the Pharmacogenomics (PGx) market, assessed using certain effective analytical tools. The report also provides strategic recommendations to market entrants to help them navigate around the entry-level barriers.

The global Pharmacogenomics (PGx) market is geographically categorized into:

The following timeline is considered for market estimation:

Historical Years: 2017-2018

Base Year: 2019

Estimated Year: 2020

Forecast Years: 2020-2027

Key Coverage of the Report:

To read more about the report, visit@ https://www.reportsanddata.com/report-detail/pharmacogenomics-pgx-market

Thank you for reading our report. For further information or queries regarding the report, please get in touch with us. Our team will make sure your report is tailored according to your requirements.

About Us:

Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development. You can rely on us to provide every significant detail you might need in your efforts to make your business flourish.

Contact Us:

John Watson

Head of Business Development

Reports and Data|Web: http://www.reportsanddata.com

Direct Line:+1-212-710-1370

E-mail: [emailprotected]

Here is the original post:
Pharmacogenomics (PGx) Market 2020: Growth by Competitive Factors, Innovative-Technology, Demands and Services Offered Till 2027 - KYT24